GlobeNewswire

AXIM Photo 1.jpg

AXIM Photo 1.jpg

AXIM Biotech presents AX-1602: the world’s first patent-pending formulation containing cannabigerol (CBG) and other cannabinoids as a treatment for psoriasis and atopic eczema.
Format

JPEG

Source

AXIM BIOTECHNOLOGIES, INC

Downloads